First Bank & Trust’s Guardant Health GH Stock Holding History

First Bank & Trust’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-11	Closed	–	–	306
2022 Q2	$0	Hold	11	–	–	﹤0.01%	518
2022 Q1	$1K	Hold	11	–	–	﹤0.01%	493
2021 Q4	$1K	Buy	+11	New	+$1.14K	﹤0.01%	487

Other funds holding GH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

First Bank & Trust's GH Position: Q3 2022 in Review

First Bank & Trust sold out of Guardant Health (GH) in Q3 2022, closing a stake of 11 shares.

First Bank & Trust first reported a position in GH in Q4 2021 and held it in 3 quarters. The position peaked at $1K in Q1 2022. 328 funds tracked by Wall St. Rank hold GH as of Q3 2022.

First Bank & Trust reported no remaining Guardant Health position as of Q3 2022 after selling out during the quarter.
First Bank & Trust sold 11 Guardant Health shares in Q3 2022.
First Bank & Trust first reported a position in Guardant Health in Q4 2021 and held it in 3 quarters.
First Bank & Trust's Guardant Health position peaked at $1K in Q1 2022.
328 funds tracked by Wall St. Rank held Guardant Health as of Q3 2022.

Based on First Bank & Trust's 13F filing for Q3 2022, filed 28 Oct 2022.